Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

WSTWest Pharmaceutical Services, Inc.

Healthcare·Medical Instruments & Supplies·NYSE·Mkt cap $25.00B
$359.74
$6.31 (+1.79%) today
IEX feed · not consolidated
Last updated Jul 14, 10:15 AM
68/100 Opportunity
37Risk
73Momentum
66Pullback
65Quality
68Valuation
99Trend
Price & History (up to 5 years)
→
Low 0.00— support · — resistanceHigh 0.00
Technical Indicators
RSI (14)66.0
MACD hist-0.55
ATR (14)7.22
SMA 20346.26
SMA 50326.95
SMA 200278.75
Rel volume0.7x
Boll upper373.44
Boll lower319.08
52w high367.57
52w low206.15
5y high468.46
5y low187.30
Hist. vol40%
Max drawdown-25%
Long-Term UptrendBuy WatchPossible Dip BuyEntry: Pullback Watch
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

West Pharmaceutical Services, Inc. — Medical Instruments & Supplies company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
68/100
Risk Level
Low-Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: WST is trading near recent levels (+1.8% today). Overall, the company is reasonably solid. The long-term trend remains up. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context50
Valuation68
Trend99
Momentum73
Pullback66
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward100
Entry Timing55
Sell Risk30
Risk37

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.